Published in Thorax on September 01, 2003
An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.73
COPD: what is the unmet need? Br J Pharmacol (2008) 0.95
Impact of nutritional status on body functioning in chronic obstructive pulmonary disease and how to intervene. Curr Opin Clin Nutr Metab Care (2008) 0.90
Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD. Thorax (2006) 0.88
Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax (2005) 0.86
Nutritional aspects of chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 0.86
Targeted treatment in COPD: a multi-system approach for a multi-system disease. Int J Chron Obstruct Pulmon Dis (2009) 0.85
Palliative management of refractory dyspnea in COPD. Int J Chron Obstruct Pulmon Dis (2006) 0.85
Multidisciplinary team-based approach for comprehensive preoperative pulmonary rehabilitation including intensive nutritional support for lung cancer patients. PLoS One (2013) 0.83
Skeletal muscle strength and endurance in recipients of lung transplants. Cardiopulm Phys Ther J (2008) 0.81
Effect of "add-on" interventions on exercise training in individuals with COPD: a systematic review. ERJ Open Res (2016) 0.81
Effects of nutraceutical diet integration, with coenzyme Q10 (Q-Ter multicomposite) and creatine, on dyspnea, exercise tolerance, and quality of life in COPD patients with chronic respiratory failure. Multidiscip Respir Med (2013) 0.80
Adenine nucleotide loss in the skeletal muscles during exercise in chronic obstructive pulmonary disease. Thorax (2005) 0.79
Sarcopaenia in chronic obstructive pulmonary disease. Thorax (2007) 0.78
Value of supplemental interventions to enhance the effectiveness of physical exercise during respiratory rehabilitation in COPD patients. A systematic review. Respir Res (2004) 0.77
Alternative strategies for exercise critical power estimation in patients with COPD. Eur J Appl Physiol (2005) 0.76
Management of dyspnea in patients with chronic obstructive pulmonary disease. Wien Med Wochenschr (2009) 0.76
Eat well to get well. Thorax (2003) 0.75
Relationship between nutritional risk and exercise capacity in severe chronic obstructive pulmonary disease in male patients. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Effect of physical training on fat-free mass in patients with chronic obstructive pulmonary disease (COPD). Ups J Med Sci (2014) 0.75
Effect of Dietary Supplementation on Body Composition, Pulmonary Function and Health-Related Quality of Life in Patients with Stable COPD. Tanaffos (2016) 0.75
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
A measure of quality of life for clinical trials in chronic lung disease. Thorax (1987) 10.87
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg (1995) 9.51
Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol (1994) 9.50
Guidelines for healthy weight. N Engl J Med (1999) 7.03
Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax (1992) 6.28
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet (2000) 3.68
Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2002) 2.50
The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax (1999) 2.45
Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax (1996) 2.33
Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation. Eur Respir J (1994) 2.31
Muscle glycogen utilization during prolonged strenuous exercise when fed carbohydrate. J Appl Physiol (1985) (1986) 2.29
Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax (2001) 1.89
Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg (2003) 1.81
Muscle triglyceride utilization during exercise: effect of training. J Appl Physiol (1985) (1986) 1.59
Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J (2002) 1.55
Nutritional state and exercise tolerance in patients with COPD. Chest (1995) 1.52
Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med (1995) 1.25
Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.22
Nutritional support for individuals with COPD: a meta-analysis. Chest (2000) 1.16
Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1997) 1.16
Interaction of training and diet on metabolism and endurance during exercise in man. J Physiol (1996) 1.09
Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.04
Nutritional supplementation in ambulatory patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1987) 0.90
Acute effects of different nutritional supplements on symptoms and functional capacity in patients with chronic obstructive pulmonary disease. Am J Clin Nutr (2001) 0.87
Is alpha-ketoisocaproyl-glutamine a suitable glutamine precursor to sustain fibroblast growth? Clin Nutr (1999) 0.86
Effect of carbohydrate rich versus fat rich loads on gas exchange and walking performance in patients with chronic obstructive lung disease. Thorax (1992) 0.86
Long-term oxygen therapy may improve skeletal muscle metabolism in advanced chronic obstructive pulmonary disease patients with chronic hypoxaemia. Respir Med (1995) 0.85
Enteropathogenicity of Aeromonas hydrophila and Plesiomonas shigelloides. J Med Microbiol (1975) 3.37
Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax (2003) 2.93
The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax (1999) 2.45
Driveway motor vehicle injuries in children. Med J Aust (2000) 2.02
Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax (2001) 1.89
Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J (2002) 1.55
The plasma ammonia response to cycle exercise in COPD. Eur Respir J (2007) 1.44
Development of a shortened version of the Breathing Problems Questionnaire suitable for use in a pulmonary rehabilitation clinic: a purpose-specific, disease-specific questionnaire. Qual Life Res (1998) 1.41
Genetic dissection of drought tolerance in chickpea (Cicer arietinum L.). Theor Appl Genet (2013) 1.40
Enterotoxicity of the so-called NAG vibrios. Ann Soc Belg Med Trop (1978) 1.25
Minimum clinically important improvement for the incremental shuttle walking test. Thorax (2008) 1.19
Osmotic adjustment in chickpea (Cicer arietinum L.) results in no yield benefit under terminal drought. J Exp Bot (2006) 1.13
Gastroschisis reduction under analgesia in the neonatal unit. J Pediatr Surg (2001) 1.10
A profile of daily activity in chronic obstructive pulmonary disease. J Cardiopulm Rehabil (2005) 1.08
Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir Med (2009) 1.06
Small bowel volvulus due to giant mesenteric lipoma. Pediatr Surg Int (2004) 1.03
Health status measurement: sensitivity of the self-reported Chronic Respiratory Questionnaire (CRQ-SR) in pulmonary rehabilitation. Thorax (2003) 1.01
Role of household animals in maintenance of cholera infection in a community. J Infect Dis (1974) 1.01
A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax (2001) 0.99
Measurement of inspiratory muscle performance with incremental threshold loading: a comparison of two techniques. Thorax (1993) 0.96
Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats. Kidney Int (1999) 0.94
Deviation and laterality of hand preference in monkeys. Cortex (1972) 0.93
Coeliac axis thrombosis associated with the combined oral contraceptive pill: a rare cause of an acute abdomen. Pediatr Surg Int (1998) 0.92
The incremental shuttle walking test in elderly people with chronic airflow limitation. Thorax (2002) 0.90
Preventing hospital admissions for COPD: role of physical activity. Thorax (2003) 0.89
Have we underestimated the efficacy of pulmonary rehabilitation in improving mood? Respir Med (2011) 0.89
Effect of propofol anaesthesia on the event-related potential mismatch negativity and the auditory-evoked potential N1. Br J Anaesth (2002) 0.87
Generic, symptom based, exercise rehabilitation; integrating patients with COPD and heart failure. Respir Med (2010) 0.84
Blunt abdominal trauma in children. J Paediatr Child Health (2000) 0.84
How long should outpatient pulmonary rehabilitation be? A randomised controlled trial of 4 weeks versus 7 weeks. Thorax (2006) 0.82
Chemoimmunoconjugate development for ovarian carcinoma therapy: preclinical studies with vinca alkaloid-monoclonal antibody constructs. Bioconjug Chem (1995) 0.82
Lung volume reduction surgery--a comparison of the long term outcome of unilateral vs. bilateral approaches. Eur J Cardiothorac Surg (2002) 0.82
Plasma ammonia response to incremental cycling and walking tests in COPD. Respir Med (2009) 0.79
Adenine nucleotide loss in the skeletal muscles during exercise in chronic obstructive pulmonary disease. Thorax (2005) 0.79
Action plans for COPD self-management. Integrated care is more than the sum of its parts. Thorax (2011) 0.79
Randomized controlled trial of ambulatory oxygen and an ambulatory ventilator on endurance exercise in COPD. Respir Med (2000) 0.79
Developing concepts in the pulmonary rehabilitation of COPD. Respir Med (2008) 0.78
Microbial agents in stools of infants and young children with and without acute diarrhoeal disease. J Trop Med Hyg (1977) 0.78
Assessing the exercise response to a bronchodilator in COPD: time to get off your bike? Thorax (2007) 0.78
Postoperative pain detracts from early health status improvement seen after video-assisted thoracoscopic lung volume reduction surgery. Eur J Cardiothorac Surg (2003) 0.77
Detecting oxygen desaturation in patients with COPD: incremental versus endurance shuttle walking. Respir Med (2008) 0.77
Duplicate publication. Thorax (2002) 0.77
[Can individualized rehabilitation improve functional independence in elderly patients with COPD?]. Rev Port Pneumol (2006) 0.76
Within-day repeatability of the endurance shuttle walk test. Physiotherapy (2009) 0.76
Review article: addressing the sexual health of patients with COPD: the needs of the patient and implications for health care professionals. Chron Respir Dis (2007) 0.75
Gastrointestinal stromal tumor: a rare cause of neonatal intestinal obstruction. Med Pediatr Oncol (2000) 0.75
Respiratory questionnaires in COPD. Thorax (2000) 0.75
Inferring the quality of hospital treatment for COPD by mortality; caution is needed. Thorax (2013) 0.75
How long should a course of rehabilitation be? Chron Respir Dis (2007) 0.75
Rehabilitation for people with chronic lung disease. Qual Health Care (1995) 0.75
Lung volume reduction surgery. Thorax (1998) 0.75
Integrated care for COPD. What exactly do we mean? Chron Respir Dis (2008) 0.75
Studies on bacteriology of cholera infection in Varanasi. Indian J Med Res (1975) 0.75
Cardiovascular manifestations in thyroid disorders. Indian Heart J (1978) 0.75
Peripheral muscle training in COPD: still much to learn. Thorax (2005) 0.75
Upper critical field, superconducting energy gaps and the Seebeck coefficient in La(0.8)Th(0.2)FeAsO. J Phys Condens Matter (2009) 0.75
Cytoplasmically determined expression of symptoms of potato virus X crosses between species of Capsicum. Nature (1968) 0.75
Effect of pumpkin mosaic virus infection on the hill reaction and primary productivity of pumpkin (Cucurbita maxima Duch.) leaves. Acta Microbiol Pol (1982) 0.75
Rhizosphere mycoflora of healthy and yellow vein mosaic virus infected okra (Abelmoschus esculentus) plants. Acta Microbiol Pol (1979) 0.75
Tuberculous meningitis developing during the course of chemotherapy for pulmonary tuberculosis. Clin Pediatr (Phila) (1968) 0.75
Induction of immunogenicity of monoclonal antibodies by conjugation with drugs. Cancer Res (1991) 0.75
Cutaneous Manifestations of Chronic Renal Failure. Indian J Dermatol Venereol Leprol (2017) 0.75
Sensitivity of vibrio group of organisms to minocycline--a new tetracycline derivative. Indian J Med Res (1976) 0.75
The tyranny of distance: telemedicine for the critically ill in rural Australia. Anaesth Intensive Care (2012) 0.75
The practical implementation of multidisciplinary pulmonary rehabilitation. Monaldi Arch Chest Dis (1998) 0.75
Fructose-1,6-diphosphate fails to limit early myocardial infarction size in a canine model. Ann Emerg Med (1993) 0.75